MidCap Financial, LLC Represents information pertaining to MidCap Financial, LLC, the lender. Mid Cap Financial LLC [Member] Bancorp Bank [Member] The Bancorp Bank Represents information pertaining to Bancorp Bank, the lender. Represents the amount of legal and consulting related expenses incurred pertaining to loss contingency. Loss Contingency Legal and Consulting Expenses Legal and consulting related expenses Period for which amount is deposited in escrow account Represents the period for which amount is deposited in escrow account. Escrow Deposit Period Uncertain Tax Positions Tax Reserve Recognized Tax reserve recorded for tax contingencies The gross amount of tax reserve pertaining to uncertain tax positions as of the balance sheet date. Product and Research Services Segment [Member] Product and research services segments Represents information pertaining to the product and research services segments of the entity. Non Statutory Stock Options [Member] Non-statutory options Represents the non-statutory stock options issued by the entity. Estimated Effective Income Tax Rate Continuing Operations Estimated annual effective tax rate (as a percent) The estimated annual effective tax rate for the current year. Range of Exercise Prices from Dollars 0.70 to Dollars 31.18 [Member] Represents information related to the exercise prices per share of stock options outstanding and exercisable between 0.70 dollars to 31.18 dollars per share. $0.70 - $31.18 Range of Exercise Prices from Dollars 0.70 to Dollars 7.50 [Member] Represents information related to the exercise prices per share of stock options outstanding and exercisable between 0.70 dollars to 7.50 dollars per share. $0.70 - $7.50 Amendment Description Range of Exercise Prices from Dollars 15.01 to Dollars 22.50 [Member] Represents information related to the exercise prices per share of stock options outstanding and exercisable between 15.01 dollars to 22.50 dollars per share. $15.01 - $22.50 Amendment Flag Range of Exercise Prices from Dollars 22.51 to Dollars 31.18 [Member] Represents information related to the exercise prices per share of stock options outstanding and exercisable between 22.51 dollars to 31.18 dollars per share. $22.51 - $31.18 Represents information related to the exercise prices per share of stock options outstanding and exercisable between 7.51 dollars to 15.00 dollars per share. $7.51 - $15.00 Range of Exercise Prices from Dollars 7.51 to Dollars 15.00 [Member] Range of Grant Prices from Dollars 2.16 to Dollars 9.75 [Member] $2.16 - $9.75 Represents the range of grant prices per unit from 2.16 dollars to 9.75 dollars per share. $2.16 - $6.75 Represents the range of grant prices per unit from 2.16 dollars to 6.75 dollars per share. Range of Grant Prices from Dollars 2.16 to Dollars 6.75 [Member] Range of Grant Prices from Dollars 6.76 to Dollars 9.75 [Member] $6.76 - $9.75 Represents the range of grant prices per unit from 6.76 dollars to 9.75 dollars per share. Schedule of Nonvested Restricted Stock Units by Grant Price Range [Table Text Block] Tabular disclosure of nonvested restricted stock units grant prices, by grouped ranges, including the upper and lower limits of the price range and the number of units under each range. Summary of total outstanding RSU's Schedule of Share Based Compensation Stock Options Additional Information [Table Text Block] Tabular disclosure of certain additional information pertaining to stock options. Summary of additional information regarding options outstanding Share Based Compensation Arrangement by Share Based Payment Award Accelerated Options [Abstract] Option Acceleration Service Concentration Risk [Member] Service concentration Reflects the percentage that revenues during the period from a specified service are to a specified benchmark, such as total net revenues, segment revenues or service line revenues. Share Based Compensation Arrangement by Share Based Payment Award Accelerated Options Weighted Average Exercise Price Represents the weighted average exercise price of the accelerated options. Weighted average exercise price of the accelerated options (in dollars per share) Share Based Compensation Arrangement by Share Based Payment Award Common Stock Reserved for Issuance [Table Text Block] Tabular disclosure of number of shares of common stock reserved for exercise of stock options available and for grant of awards other than options under the share-based compensation plan. Schedule of shares of common stock reserved for issuance Payor Concentration Risk [Member] Payor concentration Reflects the percentage that revenues in the period from one or more significant payors is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. Employee stock purchase plan estimated share options outstanding (in shares) Represents the potential outstanding number of shares reserved for issuance pursuant to the employee stock purchase plan under the share-based payment agreement. Share Based Compensation Arrangement Employee Stock Purchase Plan Equity Instruments Outstanding Number Deferred Tax Liabilities, Identified Intangible Assets Identified intangible assets Amount of deferred tax liability attributable to taxable temporary differences from identified intangible assets. Deferred tax liability for indefinite lived intangibles Deferred Tax Liabilities, Indefinite Lived Intangible Assets Indefinite lived intangible assets Amount of deferred tax liability attributable to taxable temporary differences from indefinite lived intangible assets. Research services segment Represents the research services business segment of the entity. Research Services [Member] Research Services Current Fiscal Year End Date Award Type [Axis] Integration Restructuring and Other Operating Expenses Integration, restructuring and other charges Amount charged against earnings in the period for incurred and estimated costs associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, excluding asset retirement obligations. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and costs associated with an ongoing benefit arrangement. This element also includes integration costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs. Total Document and Entity Information Legal Proceedings Civil Investigative Demand Civil Investigative Demand [Text Block] Civil Investigative Demand The entire disclosure for contingencies related to the Civil Investigative Demand issued in the course of an investigation under the federal false claims act. Integration Restructuring and Other Charges [Abstract] Integration, Restructuring and Other Charges Represents the patient service business segment whose principal focus is on the diagnosis and monitoring of cardiac arrhythmias, or heart rhythm disorders, through its core Mobile Cardiac Outpatient Telemetry (MCOT), event and Holter services. Patient Service Segment [Member] Patient Services Patient services segment Represents product business segment which was developed through the Biotel acquisition and focuses on the development, manufacturing, testing and marketing of medical devices and related software to medical companies, clinics and hospitals. Product Segment [Member] Product Product segment Represents information pertaining to LifeWatch Services, Inc. and Card Guard Scientific Survival, Ltd. Life Watch Services Inc and Card Guard Scientific Survival Ltd [Member] Lifewatch Represents the potential outstanding number of shares reserved for issuance under the share-based payment agreement. Share Based Compensation Arrangement by Share Based Payment Award, Equity Instruments Outstanding Number Common stock options and restricted stock units outstanding (in shares) Potential Common Stock Shares Outstanding Total (in shares) Represents the potential outstanding common stock held by the entity. Document Period End Date Schedule of Potential Common Stock Outstanding [Table Text Block] Summary of potential outstanding common stock Tabular disclosure of potential common stock outstanding as of the balance sheet date. ECG Scanning and Medical Services Inc [Member] ECG Scanning Represents ECG Scanning and Medical Services Inc., an acquiree of the entity. Biotel [Member] Biotel Represents Biotel, an acquiree of the entity. Represents the approximate period of achievement of certain performance targets from the date of purchase of acquisition for the payment of cash by the entity. Business Acquisition Contingent Consideration Potential Cash Payment Period Period for achievement of performance target upon which cash is required to be paid Rad Core Lab LLC [Member] RadCore Information pertaining to RadCore Lab, LLC, an acquiree of the entity. The fee, as a percentage of the loan commitment, that is payable if the entity terminates the loan agreement prior to the loan expiration date. Line of Credit Facility Loan Termination Fee Loan termination fee (as a percent) Potential maximum loan commitment The potential maximum borrowing capacity at the option of the entity. Line of Credit Facility Maximum Borrowing Capacity Option Legal Proceedings Legal Proceedings Contingencies [Text Block] Disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters. Weighted average number of shares: Basic Represents the pro forma number of basic shares or units outstanding for a period as if the business combination or combinations had been completed at the beginning of a period. Business Acquisition, Pro Forma Weighted Average Number of Share Outstanding Basic Entity [Domain] Computers and Purchased Software [Member] Computers and purchased software Represents information pertaining to computers and purchased software. Schedule of gross carrying amounts and accumulated amortization of the entity's intangible assets Tabular disclosure of intangible assets excluding goodwill, which may be broken down by segment or major class. Schedule of Intangible Assets Excluding Goodwill [Table Text Block] Signed Backlog [Member] Signed backlog Represents information pertaining to signed backlog. Represents Medicare as the organization other than the patient (first party) or health care provider (second party) involved in the financing of personal health services. Third Party Payor Medicare [Member] Medicare Unfavorable Adjustments Related to Prior Years Accounts Receivables Unfavorable adjustments related to prior year's accounts receivable Represents the amount of unfavorable adjustments related to prior year's accounts receivables. Number of major customers Represents the number of major customers of the entity. Number of Major Customers Represents the percentage of initial and committee chair awards vesting at the first anniversary of the date of grant. Share Based Compensation Arrangement by Share Based Payment Award Initial and Committee Chair Awards Percentage of Awards Vesting at First Anniversary of Grant Date Percentage of initial and committee chair grants vesting on the first anniversary of the grant date Allocated Share Based Compensation Expense Impact on Basic and Diluted Earnings Per Share Impact of stock-based compensation expense on basic and diluted earnings per share (in dollars per share) Represents the impact of share-based compensation expenses on basic and diluted earnings per share computations. Equity Incentive Plan 2003 [Member] Represents information pertaining to the 2003 Equity Incentive Plan of the entity. 2003 Option Plan Represents information pertaining to the 2008 Equity Incentive Plan of the entity. 2008 Option Plan Equity Incentive Plan 2008 [Member] Non Employee Directors Stock Option Plan 2008 [Member] Represents information pertaining to the 2008 Non-employee Directors' Stock Option Plan of the entity. Directors' Plan Share Based Compensation Arrangement by Share Based Payment Award, Estimated Future Forfeiture Rate Annualized forfeiture rate (as a percent) Represents the estimated annualized forfeiture rate for all options. Future forfeiture rate (as a percent) Share Based Compensation Arrangement by Share Based Payment Award Maximum Employee Subscription Amount Represents the highest amount out of annual salary that an employee is permitted to utilize with respect to the plan. Maximum amount that employees may contribute through payroll deductions Share Based Compensation Arrangement by Share Based Payment Award Percentage of Awards Vesting at First Anniversary of Grant Date Represents the percentage of award vesting at the first anniversary of the date of grant. Percentage of awards vesting on the first anniversary of the grant date Share Based Compensation Arrangement by Share Based Payment Award Ratable Vesting Period after First Anniversary of Grant Date Represents the period after the first anniversary of the grant date during which the share based awards vest ratably. Period after the first anniversary of the grant date in which awards vest ratably Share Based Compensation Arrangement by Share Based Payment Award Threshold Percentage for Determining Deeply Out of Money Options Represents the threshold percentage of out-of-the-money options for determining them to be deeply out-of-the-money by the entity. Threshold percentage for determining deeply out-of-the-money options Increase in the number of options available to be granted (in shares) Share Based Compensation Arrangement by Share Based Payment Increase in Options Available to be Granted Represents the maximum annual increase in the number of options available to be granted under the share-based compensation plan. Share Based Compensation Arrangement by Share Based Payment Increase in Options Available to be Granted as Percentage of Aggregate Common Shares Outstanding Represents the maximum annual increase in the number of options available to be granted the under share-based compensation plan, as a percentage of total number of common shares outstanding. Increase in the number of options available to be granted as a percentage of total number of common shares outstanding Represents the grant price of awards outstanding under the share based compensation plan. Grant price (in dollars per share) Share Based Compensation Arrangements by Share Based Payment Awards Outstanding Grant Price Information by range of grant prices for awards outstanding under share-based compensation plan. Share Based Compensation Awards Outstanding by Grant Price Range [Axis] Share Based Compensation Awards Outstanding Grant Price Range [Domain] Supplementary information on outstanding share awards, as of the balance sheet date, which stratifies outstanding awards by ranges of grant prices. Options Outstanding Share Based Compensation Shares Authorized under Stock Option Plans Exercise Price Range Options Outstanding [Abstract] Share Based Compensation Arrangement by Share Based Payment Award, Equity Instruments, Number of Shares Available for Grant [Roll Forward] Shares Available for Grant Share Based Compensation Shares Authorized under Stock Option Plans Exercise Price Range Options Exercisable [Abstract] Options Exercisable Accrued Purchases Carrying value as of the balance sheet date for accrued purchases. Accrued purchases Represents information pertaining to unsigned backlog. Unsigned Backlog [Member] Unsigned backlog Share-based Compensation Arrangement by Share Based Payment Award, Equity Instruments, Outstanding or Nonvested [Roll Forward] Number of Shares Share-based Compensation Arrangement by Share Based Payment Award, Equity Instruments, Outstanding or Nonvested Weighted Average Grant Date Fair Value [Roll Forward] Weighted Average Exercise Price Share-based Compensation Arrangement by Share Based Payment Award, Equity Instruments, Grants in Period The gross number of share based awards granted during the period. Granted (in shares) Granted (in shares) Cancelled/forfeited (in shares) Cancelled/forfeited (in shares) The number of equity-based payment instruments that were forfeited or cancelled during the reporting period. Share-based Compensation Arrangement by Share Based Payment Award, Equity Instruments, Forfeited in Period Share-based Compensation Arrangement by Share Based Payment Award, Equity Instruments Options Outstanding or Nonvested Number The number of shares reserved for issuance under stock option agreements awarded under the plan and the number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Balance at the beginning of the period (in shares) Balance at the end of the period (in shares) Share-based Compensation Arrangement by Share Based Payment Award, Equity Instruments Exercised or Vested in Period Number of share options (or share units) exercised during the period and number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period. Exercised/vesting (in shares) Balance at the end of the period (in dollars per share) Share-based Compensation Arrangement by Share Based Payment Award, Equity Instruments, Outstanding or Nonvested Weighted Average Grant Date Fair Value The weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan and the weighted average fair value of nonvested awards on equity-based plans excluding option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, revenue or profit achievement stock award plan) for which the employer is contingently obligated to issue equity instruments or transfer assets to an employee who has not yet satisfied service or performance criteria necessary to gain title to proceeds from the sale of the award or underlying shares or units. Balance at the beginning of the period (in dollars per share) Share-based Compensation Arrangement by Share Based Payment Award, Equity Instruments, Grants in Period Weighted Average Grant Date Fair Value The weighted average price at which grantees can acquire the shares reserved for issuance on stock options awarded and the weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Granted (in dollars per share) Share-based Compensation Arrangement by Share Based Payment Award, Equity Instruments Forfeitures Weighted Average Grant Date Fair Value Weighted average fair value as of the grant date of equity-based award plans that were not exercised or put into effect as a result of the occurrence of a terminating event. Cancelled/forfeited (in dollars per share) Exercised/Vesting (in dollars per share) Share-based Compensation Arrangement by Share Based Payment Award, Equity Instruments, Exercised or Vested in Period, Weighted Average Grant Date Fair Value The weighted average price at which option holders acquired shares when converting their stock options into shares and the weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement. Increase in shares available for grant under the ESOP plan as a percentage of total shares outstanding Represents the increase in shares available for grant under the Employee Stock Option Plan expressed as a percentage of the total shares outstanding. Employee Stock Ownership Plan ESOP Increase in Shares Available for Grant as Percentage of Shares Outstanding Share Based Compensation Arrangement by Share Based Payment Award, Options Number of Shares Available for Grant [Roll Forward] Shares Available for Grant Patient monitoring services provided by the entity. Patient Monitoring Service [Member] Patient monitoring services Represents the period after the first anniversary of the grant date during which the initial and committee chair share based awards vest ratably. Share Based Compensation Arrangement by Share Based Payment Award Initial and Committee Chair Awards Ratable Vesting Period after after First Anniversary of Grant Date Period after the first anniversary of the grant date in which the initial and committee chair grants vest ratably Amount of accrued liabilities assumed at the acquisition date. Accrued expenses Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Accrued Liabilities Deferred Revenue Stock options Stock option plan An arrangement whereby an employee, member of the Board of Directors, or consultant is entitled to receive in the future, subject to vesting and other restrictions, a number of shares in the entity at a specified price, as defined in the agreement. Employee Director and Consultant Stock Options [Member] Corporate and Reconciling Items [Member] Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment and items used in reconciling reportable segments' amounts to consolidated amount. Corporate and Other Represents the pro forma basic and diluted net income per share for a period as if the business combination or combinations had been completed at the beginning of a period. Business Acquisition Pro Forma Earnings Per Share Basic and Diluted Net loss per common share: Basic and Diluted (in dollars per share) Entity Well-known Seasoned Issuer Schedule of Share Based Payment Award Valuation Assumptions [Table Text Block] Schedule of weighted average assumptions used to estimate the fair value of the stock-based awards Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock-based awards, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. Entity Voluntary Filers Share Based Compensation Arrangement by Share Based Payment Award Annual Vesting Period Period over which annual grants vest Represents the period over which the annual grants of share based awards vest. Entity Current Reporting Status Civil Investigative Demand Impact [Member] Civil Investigative Demand Civil Investigative Demand issued by the U.S. Department of Justice that could have an adverse effect on the entity's financial position or results of operations. Entity Filer Category Tabular disclosure of future minimum lease payments as of the date of the latest balance sheet presented, in aggregate and for each of the five years succeeding fiscal years for operating and capital leases. Schedule of Future Minimum Rental Payments for Operating and Capital Leases [Table Text Block] Summary of the future minimum lease payments under non-cancelable operating and capital leases Entity Public Float Cardio Net Vs Mednet Litigation [Member] CardioNet v. Mednet Litigation Represents information pertaining to litigation filed by CardioNet, Inc. against Mednet Healthcare Technologies, Inc., MedTel 24, Inc., RhythmWatch LLC, and AMI Cardiac Monitoring, Inc. Entity Registrant Name Cardio Net Vs Scott Care Litigation [Member] CardioNet v. ScottCare Litigation Represents information pertaining to litigation filed by CardioNet, Inc. against The ScottCare Corporation and Ambucor Health Solutions, Inc. Entity Central Index Key Mednet and its affiliated entities Represents information pertaining to Mednet Healthcare Technologies, Inc., Heartcare Corporation of America, Inc., Universal Medical, Inc., and Universal Medical Laboratory, Inc., together the Mednet entities. Mednet entities Mednet Entities [Member] CardioNet Inc and Braemar Manufacturing LLC [Member] CardioNet, Inc. and Braemar Manufacturing, LLC Represents information pertaining to amended complaint filed by the CardioNet, Inc. and Braemar Manufacturing, LLC. Tabular disclosure of nonvested stock options and restricted stock units. Schedule of Nonvested Stock Options and Restricted Stock Units RSUs [Table Text Block] Summary of the status of unvested stock options and RSU's as of the respective balance sheet dates and changes during years Share-based Compensation Arrangement by Share Based Payment Award Equity Instruments for Cancelled and Forfeited Weighted Average Grant Date Fair Value Cancelled/forfeited (in dollars per share) Weighted-average fair value as of the grant date of equity-based award plans that were cancelled or forfeited during the period. Entity Common Stock, Shares Outstanding A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period. Share-based Compensation Arrangement by Share Based Payment Award Equity Instruments Nonvested [Roll Forward] Number of Shares Unvested at the beginning of the period (in shares) The number of non-vested equity-based payment instruments that validly exist and are outstanding as of the balance sheet date. Unvested at the end of the period (in share) Share-based Compensation Arrangement by Share Based Payment Award Equity Instruments Nonvested Number Vested (in shares) The number of equity-based payment instruments that vested during the reporting period. Share-based Compensation Arrangement by Share Based Payment Award Equity Instruments Vested in Period Share-based Compensation Arrangement by Share Based Payment Award Equity Instruments Nonvested Weighted Average Grant Date Fair Value [Roll Forward] Weighted-Average Grant-Date Fair Value A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period. Unvested at the beginning of the period (in dollars per share) The weighted-average fair value of nonvested awards on equity-based plans for which the employer is contingently obligated to issue equity instruments or transfer assets to an employee who has not yet satisfied service or performance criteria necessary to gain title to proceeds from the sale of the award or underlying shares or units. Unvested at the end of the period (in dollars per share) Share-based Compensation Arrangement by Share Based Payment Award Equity Instruments Nonvested Weighted Average Grant Date Fair Value Share-based Compensation Arrangement by Share Based Payment Award Equity Instruments Granted Weighted Average Grant Date Fair Value Granted (in dollars per share) The weighted-average fair value at grant date for equity-based awards granted during the period. Share-based Compensation Arrangement by Share Based Payment Award Equity Instruments Vested in Period Weighted Average Grant Date Fair Value Vested (in dollars per share) The weighted-average fair value as of grant date pertaining to an equity-based award plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement. Cardio Net LLC [Member] CardioNet, LLC Information pertaining to CardioNet, LLC, a wholly-owned subsidiary of BioTelemetry, Inc. CardioNet Number of Trading Days to Value Common Stock Issued in Connection with Acquisitions Number of trading days to value common stock, issued in connection with acquisition Represents the number of trading days to value common stock, issued in connection with acquisition. Biomedical Systems acquisition Information regarding the business of Biomedical Systems Corporation, including cardiac event monitoring, Holter monitoring and mobile telemetry monitoring services (other than certain ECG services and monitoring in connection with clinical trials). BMS Biomedical Systems Corporation [Member] Represents Mednet Healthcare Technologies, Inc., an acquiree of the entity. Mednet Healthcare Technologies Inc [Member] Mednet Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Long Term Debt Capital Leases Note Payable and Related Interest Long-term debt, capital leases, note payable and related interest Amount of long-term debt, capital leases, note payable and related interest assumed at the acquisition date. Schedule of Income Tax [Table] Represents the disclosure of information about income taxes. Income Tax [Line Items] Income Taxes Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Liabilities Long Term Debt Amount of assumed debt associated with acquisition Amount of long-term debt assumed at the acquisition. Interest and other loss, net The aggregate amount of income or expense from ancillary business-related activities and the amount of the cost of borrowed funds accounted for as interest expense, net. Nonoperating Income Expense and Interest Expense Net Mednet Mednet Healthcare Technologies Inc Heartcare Corporation of America Inc Universal Medical Inc and Universal Medical Laboratory Inc [Member] Represents information pertaining to Mednet Healthcare Technologies, Inc., Heartcare Corporation of America, Inc., Universal Medical, Inc., and Universal Medical Laboratory, Inc., acquirees of the entity. Document Fiscal Year Focus Cardiocore Lab Inc [Member] CardioCore Information pertaining to Cardiocore Lab, LLC, a wholly-owned subsidiary of BioTelemetry, Inc. Document Fiscal Period Focus Legal Entity [Axis] Document Type Summary of Significant Accounting Policies Accounts Payable and Accrued Liabilities Disclosure [Text Block] Accrued Expenses Accounts receivable, net of allowance for doubtful accounts of $9,801 and $7,555, at June 30, 2014 and December 31, 2013, respectively Accounts Receivable, Net, Current Accounts Payable, Current Accounts payable Accounts, Notes, Loans and Financing Receivable [Line Items] Accounts receivable Net accounts receivable Accounts Receivable [Member] Accounts Receivable Accounts Receivable, Net [Abstract] Accretion (Amortization) of Discounts and Premiums, Investments Amortization of investment premium Accrued liabilities Accrued Liabilities, Current Total Accrued professional fees Accrued Professional Fees, Current Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Less accumulated depreciation Accumulated Other Comprehensive Income Accumulated Other Comprehensive Income (Loss) [Member] Paid-in capital Additional Paid in Capital, Common Stock Paid-in Capital Additional Paid-in Capital [Member] Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net loss to net cash provided by operating activities: Advertising Expense Advertising costs incurred Advertising Costs Advertising Costs, Policy [Policy Text Block] Allocated Share-based Compensation Expense Stock-based compensation (in dollars) Stock based compensation expense incurred Expenses incurred Allowance for Doubtful Accounts Receivable, Current Accounts receivable, allowance for doubtful accounts (in dollars) Allowance for Doubtful Accounts Allowance for Doubtful Accounts [Member] Other receivable, allowance for doubtful accounts (in dollars) Allowance for Doubtful Other Receivables, Current Write-off of receivables Allowance for Doubtful Accounts Receivable, Write-offs Amortization of Intangible Assets Amortization of intangibles Amortization expense Assets, Fair Value Disclosure [Abstract] Assets: Assets Total assets Assets, Current [Abstract] Current assets: Assets [Abstract] ASSETS Total current assets Assets, Current Capital leases Assets Held under Capital Leases [Member] Available-for-sale Securities, Gross Realized Gains Realized gains recognized Unaudited Interim Financial Data Basis of Accounting, Policy [Policy Text Block] Prepaid expenses and other current assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets Accounts payable Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable Accounts receivable Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables Deferred revenue Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue Deferred tax liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Noncurrent Business Acquisition [Axis] Assumed outstanding secured debt, including interest under definitive stock purchase agreement Business Combination, Consideration Transferred, Liabilities Incurred Assumed outstanding secured debt, including interest under purchase agreement Pro Forma Information Business Acquisition, Pro Forma Information [Abstract] Total assets acquired Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Cash and cash equivalents Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents Expenses related to facility closure Business Exit Costs Schedule of unaudited pro forma information representing combined results of operations as if the acquisition had occurred at the beginning of the periods presented Business Acquisition, Pro Forma Information [Table Text Block] Value of common stock issued for acquisition at closing Business Combination, Consideration Transferred, Equity Interests Issued and Issuable Estimated fair value Business Combination, Contingent Consideration, Liability Intangible assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill Total liabilities assumed Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities Business Acquisition [Line Items] Business Acquisition Other assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets Revenue Business Acquisition, Pro Forma Revenue Business Acquisition, Acquiree [Domain] Net Loss Business Acquisition, Pro Forma Net Income (Loss) Business Combination Aggregate cash purchase price Total consideration Business Combination, Consideration Transferred Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets [Abstract] Fair value of assets acquired: Business Combination, Integration Related Costs Business Development Integration costs Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other Other liabilities Liabilities assumed: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities [Abstract] Number of shares of common stock issued for acquisition Business Acquisition, Equity Interest Issued or Issuable, Number of Shares Business Combination Disclosure [Text Block] Business Combination Additional cash to be paid upon the achievement of certain performance targets Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High Property and equipment Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment Business Combination, Acquisition Related Costs Acquisition related expense Net assets acquired Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net 2015 Capital Leases, Future Minimum Payments Due in Two Years Total Capital Leases, Future Minimum Payments Due 2018 Capital Leases, Future Minimum Payments Due in Five Years Current portion of capital leases Capital Lease Obligations, Current Long term portion of capital leases Capital Lease Obligations, Noncurrent 2016 Capital Leases, Future Minimum Payments Due in Three Years 2017 Capital Leases, Future Minimum Payments Due in Four Years Future minimum lease payments under capital leases Capital Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract] Capital lease obligations Capital Lease Obligations Incurred Thereafter Capital Leases, Future Minimum Payments Due Thereafter 2014 Capital Leases, Future Minimum Payments Due, Next Twelve Months Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents Cash and cash equivalents - beginning of period Cash and cash equivalents - end of period Cash and Cash Equivalents, Policy [Policy Text Block] Cash and Cash Equivalents Cash and Cash Equivalents, Fair Value Disclosure Cash Commitments and Contingencies Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Common Stock, Par or Stated Value Per Share Common stock, par value (in dollars per share) Common Stock Common Stock [Member] Common stock, $0.001 par value; 200,000,000 shares authorized; 26,421,886 and 25,812,754 shares issued and outstanding at June 30, 2014 and December 31, 2013, respectively Common Stock, Value, Issued Common Stock, Shares, Issued Common stock, shares issued Common Stock, Shares Authorized Common stock, shares authorized Exercise of options available and grants of awards under equity plans (in shares) Common Stock, Capital Shares Reserved for Future Issuance Common Stock, Shares, Outstanding Common stock, shares outstanding Common stock (in shares) Employee Benefit Plan Components of Deferred Tax Assets and Liabilities [Abstract] Deferred tax assets (liabilities), net Comprehensive Income (Loss), Net of Tax, Attributable to Parent Net loss and comprehensive loss Concentration Risk Type [Domain] Concentration Risk [Line Items] Concentrations of credit risk Revenue Recognition Concentration Risk Benchmark [Domain] Concentrations of Credit Risk Concentration Risk, Credit Risk, Policy [Policy Text Block] Concentration Risk Type [Axis] Concentration Risk [Table] Concentration Risk Benchmark [Axis] Concentration risk (as a percent) Concentration Risk, Percentage Consolidation Items [Domain] Principles of Consolidation Consolidation, Policy [Policy Text Block] Consolidation Items [Axis] Corporate and Other Corporate and Other [Member] Cost of Revenue [Abstract] Cost of revenues: Cost of Goods Sold Product Cost of Revenue Total cost of revenues Cost of revenue Cost of Services Research services Credit concentration risk Credit Concentration Risk [Member] State Current State and Local Tax Expense (Benefit) Current: Current Income Tax Expense (Benefit), Continuing Operations [Abstract] Federal Current Federal Tax Expense (Benefit) Total current provision for income taxes Current Income Tax Expense (Benefit) Customer relationships Customer Relationships [Member] Variable interest rate basis Debt Instrument, Description of Variable Rate Basis Credit Agreement Debt Instrument [Line Items] Schedule of Long-term Debt Instruments [Table] Aggregate amount of agreement with The Bancorp Bank Debt Instrument, Face Amount Debt Instrument, Redemption, Period [Domain] Debt Instrument, Redemption, Period [Axis] April 2019 to March 2024 Debt Instrument, Redemption, Period Two [Member] April 2014 to March 2019 Debt Instrument, Redemption, Period One [Member] Spread on variable interest rate (as a percent) Debt Instrument, Basis Spread on Variable Rate Credit Agreement Credit Agreement Debt Disclosure [Text Block] Interest rate (as a percent) Debt Instrument, Interest Rate, Stated Percentage Principal amount of monthly installment payments Debt Instrument, Periodic Payment, Principal Prepaid insurance Deferred Tax Liabilities, Prepaid Expenses Deferred tax liabilities: Deferred Tax Liabilities, Net [Abstract] Total deferred tax liabilities Deferred Tax Liabilities, Gross Federal Deferred Federal Income Tax Expense (Benefit) Deferred: Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract] Total deferred provision (benefit) for income taxes Deferred Income Tax Expense (Benefit) Deferred income tax benefit State Deferred State and Local Income Tax Expense (Benefit) Net deferred tax liability Deferred Tax Assets, Net Deferred rent Deferred Rent Credit, Noncurrent Deferred revenue Deferred Revenue, Current Deferred income tax assets before valuation allowance Total deferred tax assets Deferred Tax Assets, Gross Stock option grants Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost Other, net Deferred Tax Assets, Other Net deferred tax assets Deferred Tax Assets, Net of Valuation Allowance Deferred tax assets: Deferred Tax Assets, Net [Abstract] Allowance for doubtful accounts Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Allowance for Doubtful Accounts Net operating loss carryforwards Deferred Tax Assets, Operating Loss Carryforwards Research & development and AMT credit carryforwards Deferred Tax Assets, Tax Credit Carryforwards Less valuation allowance Deferred Tax Assets, Valuation Allowance Less valuation allowance Deferred tax liability Deferred Tax Liabilities, Net, Noncurrent Property, plant and equipment Deferred Tax Liabilities, Property, Plant and Equipment Employer's matching contribution as a percent of employees' contribution to the plan Defined Contribution Plan, Employer Matching Contribution, Percent of Match Employee's contribution to the plan (as a percent) Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay Employer's contribution Defined Contribution Plan, Cost Recognized Depreciation Depreciation expense Depreciation Depreciation, Depletion and Amortization, Nonproduction Depreciation and amortization Proprietary technology Developed Technology Rights [Member] Net loss per common share: Earnings Per Share, Basic and Diluted [Abstract] Calculation of basic and diluted net loss per share Earnings Per Share, Basic and Diluted, Other Disclosures [Abstract] Weighted average number of common shares outstanding: Basic and diluted (in dollars per share) Earnings Per Share, Basic and Diluted Basic and diluted net loss per share (in dollars per share) Basic and diluted net income (loss) per share Earnings Per Share, Policy [Policy Text Block] Net Loss Earnings Per Share [Abstract] Potential outstanding common stock Net loss per common share: Federal rate of income tax (as a percent) Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Accrued compensation Employee-related Liabilities, Current Stock options Employee Stock Option [Member] Employee Stock Purchase Plan Employee Stock [Member] Employee Service Share-based Compensation, Tax Benefit Realized from Exercise of Stock Options The tax benefit realized from the exercise of nonqualified stock options Weighted average remaining periods over which unrecognized amounts are expected to be recognized Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition Employee Severance [Member] Severance and employee related costs Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options Total compensation cost of options granted but not yet vested Employee Service Share-based Compensation, Cash Received from Exercise of Stock Options Total cash received from the exercise of stock options ESOP shares Employee Stock Ownership Plan (ESOP), Shares in ESOP [Abstract] Cardiac monitoring devices, device parts and components Equipment [Member] Equity Component [Domain] Amount deposited in escrow Escrow Deposit Fair Value Measurements, Recurring and Nonrecurring [Table] Fair Value, Hierarchy [Axis] Fair Value Measurements Fair Value Hierarchy [Domain] Fair Value of Financial Instruments Fair Value of Financial Instruments, Policy [Policy Text Block] Fair Value Measurements Fair Value Disclosures [Text Block] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair value measurements Fair Value, Inputs, Level 1 [Member] Level 1 Estimated Useful Life Finite-Lived Intangible Asset, Useful Life Total intangible assets, gross Finite-Lived Intangible Assets, Gross 2019 Finite-Lived Intangible Assets, Amortization Expense, Year Five Finite lived intangible assets Finite-Lived Intangible Assets [Line Items] 2017 Finite-Lived Intangible Assets, Amortization Expense, Year Three Estimated amortization expenses Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract] Total accumulated amortization Finite-Lived Intangible Assets, Accumulated Amortization Total Finite-Lived Intangible Assets, Net Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets by Major Class [Axis] Thereafter Finite-Lived Intangible Assets, Amortization Expense, after Year Five Schedule of estimated allocation of finite-lived and indefinite-lived intangible assets Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block] 2015 Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months 2018 Finite-Lived Intangible Assets, Amortization Expense, Year Four 2016 Finite-Lived Intangible Assets, Amortization Expense, Year Two Remainder of 2014 Finite-Lived Intangible Assets, Amortization Expense, Remainder of Fiscal Year Furniture and fixtures Furniture and Fixtures [Member] Number of patents infringed by the defendants Gain Contingency, Patents Found Infringed upon, Number Number of patents infringed Number of patents allegedly infringed Gain Contingency, Patents Allegedly Infringed upon, Number Legal proceedings Gain Contingencies [Line Items] Gain Contingencies [Table] Gain Contingency, Nature [Domain] Gain Contingencies, Nature [Axis] General and Administrative Expense General and administrative Goodwill, Impairment Loss Goodwill impairment Impairments Goodwill impairment charge Goodwill impairment Goodwill Goodwill Balance at the beginning of the period Balance at the end of the period Goodwill and Intangible Assets Goodwill and Intangible Assets Disclosure [Text Block] Goodwill Goodwill [Line Items] Changes in the carrying amounts of goodwill by segment Goodwill [Roll Forward] Goodwill, Impaired [Abstract] Goodwill Goodwill and Intangible Assets Goodwill acquired during the year Goodwill, Acquired During Period Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block] Goodwill Gross Profit Gross profit Gross profit Health Care Organization, Revenue Sources [Domain] Health Care Organization, Expenses, Net Patient services Health Care Organization, Revenue Sources [Axis] Health Care Organization, Patient Service Revenue Patient service Impairment of Long-Lived Assets Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block] Income (Loss) from Continuing Operations before Income Taxes, Extraordinary Items, Noncontrolling Interest Loss before income taxes Income (loss) before income taxes CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) Income Taxes Income Tax Authority [Domain] Income Tax Authority [Axis] Income Tax Disclosure [Text Block] Income Taxes Income Tax Expense (Benefit), Continuing Operations [Abstract] Components of income tax (benefit) provision Income tax provision (benefit) Income tax benefit Benefit from income taxes Benefit (provision) for income taxes Income Tax Expense (Benefit) Increase in valuation allowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount Reconciliation between expected income taxes computed at the federal rate and the provision (benefit) for income taxes Effective Income Tax Rate Reconciliation, Amount [Abstract] Stock-based compensation Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Compensation Cost, Amount Income Taxes Paid, Net Cash paid for taxes Nondeductible goodwill impairment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Amount Income tax benefit at statutory rate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount Income Taxes Income Tax, Policy [Policy Text Block] State income tax, net of federal benefit Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount Other Effective Income Tax Rate Reconciliation, Other Adjustments, Amount Accrued and other liabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities Accounts receivable Increase (Decrease) in Accounts Receivable Increase (Decrease) in Accounts Payable Accounts payable Increase (Decrease) in Operating Capital [Abstract] Changes in operating assets and liabilities: Increase (Decrease) in Inventories Inventory Increase (Decrease) in Prepaid Expense and Other Assets Prepaid expenses and other assets Increase (Decrease) in Shareholders' Equity Increase (Decrease) in Stockholders' Equity [Roll Forward] Indefinite-lived Intangible Assets [Axis] Indefinite-lived trade name Indefinite-Lived Intangible Assets (Excluding Goodwill) Indefinite-lived Intangible Assets, Major Class Name [Domain] Intangible Assets, Net (Excluding Goodwill) Intangible assets, net Total intangible assets, net Interest Paid, Net Cash paid for interest Federal Internal Revenue Service (IRS) [Member] Inventory, Net Inventory Total inventories Finished goods Inventory, Finished Goods, Net of Reserves Inventory Inventory Disclosure [Text Block] Raw materials and supplies Inventory, Raw Materials and Supplies, Net of Reserves Inventory Inventory, Net, Items Net of Reserve Alternative [Abstract] Inventory Inventory, Policy [Policy Text Block] Inventory Investment Income, Amortization of Premium Amortization of investment premiums Available-for-Sale Investments Available-for-Sale Investments Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block] Rent expense Operating Leases, Rent Expense Leasehold improvements Leasehold Improvements [Member] Legal Fees Legal fees Total current liabilities Liabilities, Current Liabilities and Equity Total liabilities and stockholders' equity Liabilities, Current [Abstract] Current liabilities: Total liabilities Liabilities LIABILITIES AND STOCKHOLDERS' EQUITY Liabilities and Equity [Abstract] Amount withdrawn for acquisition Line of Credit Facility, Increase (Decrease), Net Unused line fee (as a percent) Line of Credit Facility, Unused Capacity, Commitment Fee Percentage Line of Credit Facility, Lender [Domain] Loan commitment Line of Credit Facility, Maximum Borrowing Capacity Amount of outstanding balance on the credit agreement Line of Credit Facility, Amount Outstanding Lender Name [Axis] Litigation Case [Domain] Litigation Case [Axis] Current portion of long term debt Long-term Debt, Current Maturities Long term debt Long-term Debt, Excluding Current Maturities Estimated total cash settlement amount Loss Contingency, Estimate of Possible Loss Loss Contingency, Nature [Domain] Loss Contingencies [Table] Legal proceedings Loss Contingencies [Line Items] Civil Investigative Demand Accrual of contingent liabilities Loss Contingency Accrual Loss Contingency Nature [Axis] Amount of non-operating charge Loss Contingency, Loss in Period Marketing and Advertising Expense [Abstract] Advertising Costs Maximum [Member] Maximum Minimum Minimum [Member] Allowance for Doubtful Accounts Movement in Valuation Allowances and Reserves [Roll Forward] Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract] Financing activities Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract] Operating activities Net (decrease) increase in cash and cash equivalents Net Cash Provided by (Used in) Continuing Operations Net Income (Loss) Available to Common Stockholders, Basic Net loss Numerator: Net loss (in dollars) Net loss and comprehensive loss Net income (loss) Net Cash Provided by (Used in) Operating Activities, Continuing Operations Net cash provided by operating activities Net Cash Provided by (Used in) Financing Activities, Continuing Operations Net cash provided by financing activities Net Cash Provided by (Used in) Investing Activities, Continuing Operations Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract] Investing activities Net loss Net (loss) income Net Income (Loss) Attributable to Parent New Accounting Pronouncements, Policy [Policy Text Block] Recent Accounting Pronouncements Covenants not to compete Noncompete Agreements [Member] Covenants not to compete Nonoperating Income (Expense) Other (loss), net Other income, net Number of operating segments Number of Operating Segments Number of reporting segments prior to acquisition of Cardiocore Number of Reportable Segments Number of reportable segments Number of reporting units Thereafter Operating Leases, Future Minimum Payments, Due Thereafter Future minimum lease payments under non-cancelable operating leases Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract] Operating Expenses [Abstract] Operating expenses: 2017 Operating Leases, Future Minimum Payments, Due in Four Years Operating Expenses Total expenses 2018 Operating Leases, Future Minimum Payments, Due in Five Years 2016 Operating Leases, Future Minimum Payments, Due in Three Years 2014 Operating Leases, Future Minimum Payments Due, Next Twelve Months Operating Income (Loss) Loss from operations Income (loss) from operations Operating Loss Carryforwards [Table] Net Operating Loss Carryforwards Operating Loss Carryforwards [Line Items] Operating segments Operating Segments [Member] 2015 Operating Leases, Future Minimum Payments, Due in Two Years Total Operating Leases, Future Minimum Payments Due Net operating loss carryforwards Operating Loss Carryforwards Organization and Description of Business Organization and Description of Business Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Other Assets, Noncurrent Other assets Other Receivables, Net, Current Other receivables, net of allowance for doubtful accounts of $259 and $85 at June 30, 2014 and December 31, 2013, respectively Total other income Other Nonoperating Income (Expense) Other Liabilities, Noncurrent Other long term liabilities Other income (expense): Other Nonoperating Income (Expense) [Abstract] Other charges Other Nonrecurring Expense Other Other Accrued Liabilities, Current Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent [Abstract] Other comprehensive loss: Changes in unrealized gain on available-for-sale investments Unrealized holding gains/(losses) arising during the period Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, before Tax, Portion Attributable to Parent [Abstract] Unrealized gains/(losses) on securities: Products and Services [Domain] Accrued Expenses Settlement amount paid Payments for Legal Settlements Capital expenditures Payments to Acquire Productive Assets Acquisition of business, net of cash acquired Payments to Acquire Businesses, Net of Cash Acquired Payments to Acquire Available-for-sale Securities Purchases of short-term available-for-sale investments Purchase consideration in cash Payments to Acquire Businesses, Gross Cash consideration paid under the Purchase Agreement Payments to Acquire Property, Plant, and Equipment Purchases of property and equipment Employee Benefit Plan Pension and Other Postretirement Benefits Disclosure [Text Block] Plan Name [Domain] Plan Name [Axis] Litigation settled Positive Outcome of Litigation [Member] Preferred stock, shares authorized Preferred Stock, Shares Authorized Preferred stock, shares outstanding Preferred Stock, Shares Outstanding Prepaid Expense and Other Assets, Current Prepaid expenses and other current assets Net proceeds from the issuance of shares of common stock (in dollars) Proceeds from Issuance of Shares under Incentive and Share-based Compensation Plans, Excluding Stock Options Proceeds from the issuance of shares of common stock (in dollars) Issuance of long-term debt Proceeds from Issuance of Long-term Debt Proceeds from issuance of common stock Proceeds from Issuance of Common Stock Issuance of common stock Proceeds from Sale and Maturity of Available-for-sale Securities Sale or maturity of short-term available-for-sale investments Proceeds from the exercise of employee stock options and employee stock purchase plan contributions Proceeds from Issuance of Shares under Incentive and Share-based Compensation Plans, Including Stock Options Products and Services [Axis] Professional Fees Professional fees Estimated Useful Life Property, Plant and Equipment, Useful Life Total property and equipment, at cost Property, Plant and Equipment, Gross Property and Equipment Property, Plant and Equipment, Policy [Policy Text Block] Property, Plant and Equipment, Net Property and equipment, net Total property and equipment, net Property and Equipment Property, Plant and Equipment [Table Text Block] Schedule of Property and equipment Property, Plant and Equipment, Type [Domain] Property, Plant and Equipment, Type [Axis] Property and Equipment Property, Plant and Equipment Disclosure [Text Block] Property and equipment Property, Plant and Equipment [Line Items] Provision for Doubtful Accounts Provision for doubtful accounts Bad debt expense Additional bad debt expense Quarterly Financial Data (Unaudited) Quarterly Financial Information [Text Block] Quarterly Financial Data (Unaudited) Range [Axis] Range [Domain] Principal payments on capital lease obligations Repayments of Long-term Capital Lease Obligations Repayment of long-term debt Repayments of Long-term Debt Research and Development Expense Research and development Research and Development Costs Research and Development Expense, Policy [Policy Text Block] Restricted Stock Units (RSUs) [Member] RSU's Accrued restructuring costs Restructuring Reserve, Current Restructuring Type [Axis] Integration, Restructuring and Other Charges Integration, Restructuring and Other Charges Restructuring and Related Activities Disclosure [Text Block] Restructuring Cost and Reserve [Line Items] Integration, restructuring and other charges Accumulated Deficit Retained Earnings [Member] Accumulated deficit Retained Earnings (Accumulated Deficit) Revenue Recognition Revenue Recognition, Policy [Policy Text Block] Segment Reporting Information, Intersegment Revenue (Deprecated 2013-01-31) Revenues Total revenues Revenues Total revenues Revenues [Abstract] Revenues: Increase (decrease) in deferred rent Straight Line Rent Shareholders' Equity Shareholders' Equity and Share-based Payments [Text Block] Weighted - Average Exercise Price (in dollars per share) Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Exercisable Options, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value Aggregate intrinsic value of options exercisable at year-end Number of previously unvested shares, which became fully vested as a result of option acceleration Share-based Compensation Arrangement by Share-based Payment Award, Accelerated Vesting, Number Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term Expected life Weighted - Average Remaining Contractual Life Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Exercisable Options, Weighted Average Remaining Contractual Term Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price Weighted - Average Exercise Price (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent Purchase price as a percentage of the fair market value Percentage of the fair market price on the first day of the offering period or the market price as on the day of purchase Expiration period Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term Weighted average remaining contractual life Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Summary of estimated amortization expense for the next five years Sales Revenue, Goods, Net Product Revenue Sales Revenue, Net [Member] Sales Revenue, Services, Net Research services Schedule of the preliminary fair value estimates of assets acquired and liabilities assumed Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] Schedule of Available-for-sale Securities [Table] Schedule of option activity under all stock award plans Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block] Schedule of weighted average assumptions used to estimate the fair value of the stock-based awards Schedule of the weighted average assumptions used in estimating the fair value of stock options granted Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Schedule of the components of the entity's income tax (benefit) provision Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] Schedule of inventory Schedule of Inventory, Current [Table Text Block] Schedule of reconciliations between expected income taxes computed at the federal rate and the provision (benefit) for income taxes Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Schedule of the components of the entity's deferred tax assets and liabilities Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Schedule of accrued expenses Schedule of Accrued Liabilities [Table Text Block] Schedule of Finite-Lived Intangible Assets [Table] Schedule of Share-based Compensation, Activity [Table Text Block] Summary of option and RSU activity under all equity incentive plans Schedule of Quarterly Financial Information [Table Text Block] Summary of the unaudited quarterly financial data Schedule of calculation of basic and diluted net loss per share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Schedule of Available-for-sale Securities [Line Items] Available-for-sale investments Schedule of Business Acquisitions, by Acquisition [Table] Schedule of changes in the carrying amounts of goodwill by segment Schedule of Goodwill [Table Text Block] Schedule of estimated allocation of finite-lived intangible assets Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block] Schedule of Goodwill [Table] Schedule of Segment Reporting Information, by Segment [Table Text Block] Summary of financial information concerning the entity's reportable segments Schedule of Restructuring and Related Costs [Table] Property, Plant and Equipment [Table] Restructuring and Related Costs [Table Text Block] Summary of expenses related to restructuring, integration and other activities Schedule of Restructuring Reserve by Type of Cost [Table Text Block] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Segment Reporting Information, by Segment [Table] Schedule II-Valuation and Qualifying Accounts and Reserves Schedule of Valuation and Qualifying Accounts Disclosure [Text Block] Schedule of Accounts, Notes, Loans and Financing Receivable [Table] Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table] Summary of total outstanding stock options Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block] Schedule of additional information regarding options outstanding Segment Reporting Information [Line Items] Segment information Segments [Domain] Segment Information Segment Information Segment Reporting, Policy [Policy Text Block] Segment Reporting Disclosure [Text Block] Segment Information Segment Information Segment Reporting, Disclosure of Entity's Reportable Segments [Abstract] Selling and Marketing Expense Sales and marketing Severance and employee related costs Severance Costs Share-based Compensation Arrangement by Share-based Payment Award Accelerated Compensation Cost Expense associated with the accelerated options Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Weighted Average Exercise Price Granted (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Canceled (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number RSU's Outstanding (in shares) Increase in number of shares available for grant Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized Additional options available for grant (in shares) Additional shares authorized for grant Share-based Compensation Stock-based compensation Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Stock-based compensation Employee stock purchase plan Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Exercised (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures Granted (in shares) Granted (in shares) Expected dividend yield (as a percent) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Canceled (in shares) Canceled (in shares) Maximum percentage of compensation that employees may contribute through payroll deductions Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] Additional disclosures Number of remaining shares available for purchase Shares remained available for future grant under the Plan Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant Common stock options and restricted stock units available for grant (in shares) Balance at the beginning of the period (in shares) Balance at the end of the period (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value Aggregate intrinsic value of options exercised during the year Expected volatility (as a percent) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Risk-free interest rate (as a percent) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract] Assumptions used for estimating the fair value of stock options granted Weighted average assumptions used to estimate the fair value of the stock-based awards Weighted average fair value of the options granted (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Balance at the beginning of the period (in dollars per share) Balance at the end of the period (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block] Stock-Based Compensation Common stock purchased (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Shares Purchased for Award Balance at the beginning of the period (in shares) Balance at the end of the period (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items] Additional information regarding options outstanding Summary of total outstanding stock options Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Aggregate intrinsic value of options outstanding at year-end Exercise Price Range [Axis] Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Domain] Number of Shares Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Equity Award [Domain] Range of exercise prices, low end of range (in dollars per share) Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Lower Range Limit Number Outstanding (in shares) Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options Number Exercisable (in shares) Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options Range of exercise prices, high end of range (in dollars per share) Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Upper Range Limit Balance (in shares) Balance (in shares) Shares, Issued Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Internally Developed Software Software Development [Member] State State and Local Jurisdiction [Member] Statement [Table] Statement [Line Items] Statement CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY CONSOLIDATED STATEMENTS OF CASH FLOWS Equity Components [Axis] CONSOLIDATED BALANCE SHEETS Segments [Axis] Stock Issued During Period, Shares, Period Increase (Decrease) Shares of common stock issued under definitive stock purchase agreement Stock Issued During Period, Shares, Acquisitions Shares of common stock issued under purchase agreement Number of common stock issued for acquisition (in shares) Value of common stock issued under the Purchase Agreement Stock Issued During Period, Value, Acquisitions Exercise of stock options and purchase of shares related to the employee stock purchase plan Stock Issued During Period, Value, Employee Stock Purchase Plan Stock based compensation (in shares) Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Exercised (in shares) Exercise of stock options and purchase of shares related to the employee stock purchase plan (in shares) Stock Issued During Period, Shares, Employee Stock Purchase Plans Stock based compensation Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures Stockholders' Equity Attributable to Parent [Abstract] Shareholders' equity: Stockholders' Equity, Period Increase (Decrease) Stockholders' Equity Attributable to Parent Total stockholders' equity Balance Balance Shareholders' Equity Subsequent Events Subsequent Events [Text Block] Subsequent Events Subsequent Event [Table] Subsequent events Subsequent Event [Line Items] Subsequent event Subsequent Event [Member] Subsequent Event Type [Domain] Subsequent Event Type [Axis] Supplemental Cash Flow Information [Abstract] Supplemental disclosure of cash flow information Equipment, tools and molds Tools, Dies and Molds [Member] Trade Names [Member] Indefinite-lived trade name Trade and Other Accounts Receivable, Policy [Policy Text Block] Accounts Receivable Type of Restructuring [Domain] Use of Estimates Use of Estimates, Policy [Policy Text Block] Valuation and Qualifying Accounts Disclosure [Table] Valuation Allowances and Reserves [Domain] Additions Charged To Expense Valuation Allowances and Reserves, Charged to Cost and Expense Beginning Balance Ending Balance Valuation Allowances and Reserves, Balance Valuation Allowances and Reserves, Deductions Deductions From Reserve Schedule II-Valuation and Qualifying Accounts and Reserves Schedule II Valuation and Qualifying Accounts Disclosure [Line Items] Valuation Allowances and Reserves Type [Axis] Weighted Average Number of Shares Outstanding, Basic Denominator: Weighted average common shares outstanding-Basic Weighted Average Number of Shares Outstanding, Basic and Diluted Basic and diluted (in shares) Denominator: Weighted average shares used in computing basic and diluted net loss per share